CNR1 and nervous system disorder: Synthetic cannabinoids [83] are agonists at the CB1 and CB2 cannabinoid receptors, but also ion channels and PPAR receptors, where they can produce severe adverse effects, including disinhibition, euphoria, neurological disorders, agitation, irritability, paranoia, psychiatric conditions and death.